Nevada’s Medical Cannabis Retail Market Is Down to One Store

Nevada is down to one medical-only dispensary while 105 adult-use stores keep trading

Nevada’s separate medical cannabis retail channel has almost disappeared.

The Nevada Cannabis Compliance Board’s August 2026 establishment statistics show 346 active operational cannabis licenses statewide. Inside that total, there is 1 licensed medical cannabis dispensary and 105 adult-use retail cannabis stores, meaning stores open to adults 21 and older without a patient card now define the state’s retail market.

The board’s current licensee roster puts a name to that last holdout. Green Cross Farmacy is the only storefront listed as “Medical Only.” The rest of Nevada’s operating retail footprint sits in the adult-use market, whether as adult-use shops alone or as businesses that also serve medical patients under a dual-license structure.

That number is news now because it turns an old trend into a live policy problem. In April, Nevada’s cannabis regulator and tax department said federal rescheduling guidance could create a path for state medical cannabis licensees to register with the Drug Enforcement Administration, the federal agency that oversees controlled-drug registrations. At the same time, the state warned that businesses holding both medical and adult-use licenses should not assume they would qualify for the same treatment, and should not assume relief from 280E, the federal tax rule that blocks most normal business deductions for cannabis companies.

That means a category that had started to look mostly symbolic now has fresh practical value. Nevada still has a medical cannabis system in law. What the August 2026 data show is that it barely still has one as a standalone retail market.

This matters beyond a licensing spreadsheet. Store counts are a market signal. They show where businesses believe demand sits, where compliance costs can be justified, and which legal distinctions still have commercial weight. A state with one medical-only dispensary is a state where the medical storefront model has, for almost every operator, stopped making business sense.

Nevada’s rules let medical sales move inside the adult-use network

The basic structure explains the decline.

Nevada built a medical cannabis system first and then added adult-use sales. State law still preserves separate licensing concepts for medical dispensaries and for the broader regulated cannabis market. The medical-use chapter keeps patient status, medical authorizations and dispensary permissions on the books. The licensing chapter gives the regulator authority over the different classes of cannabis businesses. On paper, the medical channel still exists as a distinct part of the system.

In practice, Nevada also gave businesses a way to collapse the customer-facing side of those two markets together. State law and Regulation 6 allow a medical dispensary to operate as a dual licensee, meaning the same business can hold medical and adult-use retail authority and run both from one location if it meets the state’s operational rules. Those rules are not decorative. They cover inventory control, compliance, and how medical and non-medical sales are handled. But their market effect is simple enough: a business does not need a separate medical-only storefront to keep serving patients.

That one design choice changed the commercial logic of retail.

A medical-only store can sell only to registered patients and caregivers. An adult-use store can reach the much larger pool of ordinary consumers, including local residents and visitors. A dual-license store can do both. Once that option exists, a standalone medical store has to justify its rent, staffing and compliance costs on a far smaller customer base.

Nevada’s sales data show how hard that case became to make. The state’s official release on annual cannabis taxable sales said licensed adult-use stores and medical dispensaries generated $757.7 million in taxable sales in fiscal year 2025. The state-commissioned market analysis released by the board describes the sales mix in plain terms: Nevada’s market is overwhelmingly adult-use, and the medical market has contracted.

That finding fits the store count. The standalone medical shop did not disappear because Nevada repealed medical cannabis. It disappeared because the market learned it could keep the legal ability to serve patients without keeping a separate patient-only retail footprint.

This is what hollowing out looks like in a regulated market. The law preserves a category. Operators retain a path to sell under that category. But the visible, dedicated channel for it withers because another channel offers more volume with the same address, the same staff base and fewer commercial limits.

For patients, this does not necessarily mean loss of access in a simple geographic sense. A patient can still be served by a dual-license store. But it does mean that the medical market increasingly lives inside businesses whose shelves, staffing model and daily traffic are shaped by the economics of adult-use retail. That is a very different thing from a separate medical storefront sector.

The last medical-only license matters more because federal tax treatment is still unsettled

The sudden importance of that distinction comes from federal policy, not just state market structure.

In April, Nevada issued a joint statement on federal medical marijuana rescheduling. The statement said the federal order created a path for Nevada medical cannabis establishments to seek federal registration. It also said something more restrictive and more important for most operators: the change does not automatically apply to Nevada dual-licensees, and there is still no guarantee of 280E tax relief without further Internal Revenue Service guidance.

That is a narrow message, but it has wide consequences.

For years, many cannabis businesses treated the difference between “medical” and “adult-use” as commercially secondary once dual operations were allowed. The April statement suggests that federal law may now care about that line more than the Nevada market does. If a business is clearly and solely inside the state medical category, it may have a cleaner argument for federal registration and, eventually, for different tax treatment. If it is a mixed business selling to both patients and ordinary adult consumers, Nevada itself is warning that the answer is not automatic.

With only one medical-only dispensary on the state roster, that leaves most Nevada retailers outside the cleanest version of the category that might benefit.

This is where the store count stops being a curiosity and becomes an operating issue. Owners, accountants and lawyers working on cannabis tax planning now have a market in which the potentially advantaged license class barely exists as a storefront reality. A business cannot easily benefit from being a pure medical operator if its whole retail model, staffing structure and customer base were built around the dual-license or adult-use framework.

The same point runs through supply decisions. Growers, manufacturers and brands can still sell into a patient-serving system through dual stores, but there is no meaningful statewide network of medical-only shelves left to anchor a distinct medical retail strategy. That does not eliminate patient demand. It does mean most product planning will continue to follow the volume center of gravity, which in Nevada is adult-use.

For regulators, this creates an awkward split between law and lived market structure. The state still has to maintain the medical framework because it governs patient access and because federal changes may make the category newly important. But maintaining a framework is not the same as maintaining a channel. Nevada has preserved the form of a medical retail system while allowing almost all of its dedicated storefronts to disappear.

That split matters to investors and buyers as well, although not in the way licensing headlines sometimes suggest. One medical-only store does not mean scarcity value by itself. It means that any value attached to that status depends on unresolved federal treatment. Until tax authorities and federal drug regulators give clearer answers, the market cannot price the medical-only category with confidence.

Nevada has preserved the medical label more than the medical storefront

The August snapshot points to a harder conclusion than a simple count of closures or conversions.

Nevada has not ended medical cannabis retail by formal act. It has done something quieter. It has let the dedicated medical storefront become optional almost to the point of extinction, while keeping the legal category alive inside a much larger adult-use market.

That might have looked efficient when the issue was only consumer demand. If dual-license stores can serve patients and also attract ordinary adult consumers, the commercial case for mixed operations is obvious. The market followed that logic. The state’s own commissioned analysis says adult-use dominates. The live licensing data now show what dominance becomes after enough time passes: one medical-only storefront left in the entire state.

The trouble is that efficiency in one part of the system can create fragility in another. If federal agencies ultimately give clearer advantages to state medical licensees, Nevada will discover that it preserved the legal architecture more successfully than it preserved the businesses that fit neatly inside it. A state can keep a category on paper and still lose the practical benefits of having a functioning channel.

That does not mean Nevada needs to rebuild a large standalone medical network. The evidence does not support that as an obvious market outcome. It does mean the state may eventually have to decide what its medical system is actually for.

One option is to treat medical cannabis mainly as a patient status layered onto the adult-use market. Under that approach, the real retail system is adult-use, and the medical rules exist to protect patient eligibility and any related benefits. Another option is to clarify, and possibly strengthen, what it means to be a true medical operator if federal registration and tax treatment start to reward that status in concrete ways.

Right now, Nevada sits between those two positions. It still speaks the language of a separate medical system. Its store count says the market no longer behaves as if that separate system needs its own retail footprint.

That is the real significance of one store. It is not just evidence of attrition. It is evidence that the state’s medical channel has been reduced to a legal category with almost no physical presence of its own. If federal law begins to attach real advantages to that category, Nevada may find that the market has already moved on.

In Nevada, the medical license still exists. The medical store network, for practical purposes, no longer does.